User contributions
Jump to navigation
Jump to search
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)
- 18:41, 11 June 2019 (diff | hist) (-39) ICRP Glossary (→I)
- 18:40, 11 June 2019 (diff | hist) (+379) N Individual-related (Created page with "Of, or relating to, the radiation exposure of a specific individual. It is contrasted with another term, “source-related”. Note that this term is used when the assessment...")
- 18:40, 11 June 2019 (diff | hist) (+25) ICRP Glossary (→I)
- 18:37, 11 June 2019 (diff | hist) (+345) N Individual monitoring (Created page with "Monitoring using measurements taken from devices worn by individuals, or measurements of quantities of radioactive substances in or on individuals, or measurements of quantiti...")
- 18:35, 11 June 2019 (diff | hist) (+36) ICRP Glossary (→H)
- 18:20, 11 June 2019 (diff | hist) (+264) N Dose-threshold (Created page with "A dose level above which a given health effect is expected to result. For a tissue reaction (or deterministic effect), ICRP takes the dose threshold at a dose level where 1% o...")
- 18:18, 11 June 2019 (diff | hist) (-26) ICRP Glossary (→D)
- 18:16, 11 June 2019 (diff | hist) (-23) ICRP Glossary (→D)
- 18:11, 11 June 2019 (diff | hist) (+122) N Class SR-2 gases (Created page with "Highly soluble and reactive gases and vapours. (ICRP Publication 119, 2012) ''ICRP Glossary entry - June 2019''")
- 18:10, 11 June 2019 (diff | hist) (+115) N Class SR-1 gases (Created page with "Soluble and reactive gases and vapours. (ICRP Publication 119, 2012) ''ICRP Glossary entry - June 2019''")
- 18:09, 11 June 2019 (diff | hist) (+121) N Class SR-0 gases (Created page with "Insoluble and non-reactive gases and vapours. (ICRP Publication 119, 2012) ''ICRP Glossary entry - June 2019''")
- 18:03, 11 June 2019 (diff | hist) (+246) N Xerostomia (Created page with "Dryness of the mouth caused by malfunctioning salivary glands or composition of saliva. Xerostomia is also known to be caused by radiotherapy of the head and neck region. (I...")
- 18:02, 11 June 2019 (diff | hist) (+330) N Valvular heart disease (Created page with "Heart disease due to one or more abnormal heart valves. Abnormally narrowed or leaky heart valves can interfere with the heart’s ability to push blood forward from chamber t...")
- 18:01, 11 June 2019 (diff | hist) (-20) ICRP Glossary (→T)
- 18:01, 11 June 2019 (diff | hist) (+429) N Transforming growth factor (Created page with "A cytokine that regulates many of the biological processes essential for embryo development and tissue homeostasis, and which therefore plays a role in tissue healing. The eff...")
- 17:59, 11 June 2019 (diff | hist) (-31) ICRP Glossary (→T)
- 17:59, 11 June 2019 (diff | hist) (+237) N Time factor (Created page with "Describes the change in iso-effective total dose for local tumour control or normal tissue complications that follows a change in the overall treatment duration. (ICRP Publi...")
- 17:57, 11 June 2019 (diff | hist) (-18) ICRP Glossary (→T)
- 17:57, 11 June 2019 (diff | hist) (-15) ICRP Glossary (→S)
- 17:56, 11 June 2019 (diff | hist) (+392) N Subcutaneous tissue (Created page with "Loose fibrous tissue situated directly below the skin. It includes blood vessels, connective tissue, muscle, fat and glands. In the context of intake through wounds, it repres...")
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)